Ratings ICL Group Ltd Nyse

Equities

ICL

IL0002810146

Market Closed - Nyse Other stock markets 01:32:37 01/06/2024 am IST			5-day change	1st Jan Change
4.73 ^USD	+0.42%		-2.87%	-5.59%

31/05	ICL Group Ltd Announces Not Standing for Reelection of Dafna Gruber as Additional External Director	CI
13/05	Iceni Gold Raises AU$1.7 Million for Gold Exploration at 14 Mile Well Project; Shares Fall 12%	MT

Strengths

The company's share price in relation to its net book value makes it look relatively cheap.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last few months, analysts have been revising downwards their earnings forecast.

Ratings chart - Surperformance

Sector: Agricultural Chemicals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
ICL GROUP LTD	-5.59%	6.01B		-
CORTEVA, INC.	+16.74%	38.99B		C
PHOSAGRO	-.--%	11.36B	-	B+
FMC CORPORATION	-3.33%	7.61B		A
PI INDUSTRIES LIMITED	+1.10%	6.45B		B-
OCI N.V.	-4.50%	5.73B		B
YUNNAN YUNTIANHUA CO., LTD.	+32.88%	5.25B		B-
THE FERTILISERS AND CHEMICALS TRAVANCORE LIMITED	-16.30%	5.23B	-	C-
UPL LIMITED	-13.40%	4.58B		C+
THE SCOTTS MIRACLE-GRO COMPANY	+9.35%	3.96B		B-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes